e-learning
resources
ERJ
2011
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The rise and fall of endothelin receptor antagonists in congestive heart failure
Handoko M.L., de Man F.S., Vonk-Noordegraaf A.
Source:
Eur Respir J 2011; 37: 484-485
Journal Issue:
March
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Handoko M.L., de Man F.S., Vonk-Noordegraaf A.. The rise and fall of endothelin receptor antagonists in congestive heart failure. Eur Respir J 2011; 37: 484-485
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Oral vasopressin receptor antagonist tolvaptan in right heart failure due to pulmonary hypertension
Source: Eur Respir J 2015; 46: 283-286
Year: 2015
Bosentan does not improve pulmonary hypertension and lung remodeling in heart failure
Source: Eur Respir J 2011; 37: 578-586
Year: 2011
Effect of adaptive servo-ventilation on plasma endothelin-1 levels in patients with congestive heart failure and Cheyne-Strokes respiration
Source: Eur Respir J 2005; 26: Suppl. 49, 37s
Year: 2005
Theophylline increases muscle sympathetic activity in patients with congestive heart failure
Source: Annual Congress 2003 - Management of sleep related breathing disorders
Year: 2003
Endothelin receptor antagonists in pulmonary arterial hypertension
Source: Eur Respir J 2008; 31: 407-415
Year: 2008
Pulmonary hypertension in COPD
Source: Eur Respir Mon 2013; 59: 189-205
Year: 2013
Beta blockers in heart failure and airways disease
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
Endothelin: setting the scene in PAH
Source: Eur Respir Rev 2008; 17: 3-7
Year: 2007
The endothelin-receptor antagonist bosentan for the treatment of pulmonary arterial hypertension (PAH) associated with congenital heart defects (CHD)
Source: Annual Congress 2004 - Treatment of pulmonary hypertension
Year: 2004
Dual endothelin receptor antagonism: setting standards in PAH
Source: Eur Respir Rev 2008; 17: 13-18
Year: 2007
Are beta-blockers able to prevent sleep apnoea in congestive heart failure?
Source: Breathe 2008; 5: 76
Year: 2008
Adrenergic receptor blocker reverses cardiac metabolic remodeling and improves right ventricular function in experimental pulmonary hypertension
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011
Endothelin receptor expression in idiopathic pulmonary arterial hypertension: effect of bosentan and epoprostenol treatment
Source: Eur Respir J 2011; 38: 851-860
Year: 2011
Effect of acute beta-blocker withholding on the ventilatory efficiency in patients with advanced chronic congestive heart failure
Source: Annual Congress 2009 - Novel insights in exercise physiology from cells to humans
Year: 2009
Monitoring of liver function in patients with pulmonary hypertension treated with endothelin receptor antagonists: The value of a novel monitoring system
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011
Bosentan therapy for portopulmonary hypertension
Source: Eur Respir J 2005; 25: 502-508
Year: 2005
Single centre experience with endothelin receptor blockade in pulmonary hypertension
Source: Annual Congress 2004 - Pulmonary hypertension
Year: 2004
Impact of beta-blockers on sleep-disoredered breathing in chronic heart failure
Source: Eur Respir J 2007; 30: Suppl. 51, 509s
Year: 2007
Inhalation of endothelin receptor blockers in pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
Long-term monitoring of respiratory function and influence of selective beta blockers on its decline in COPD patients with concomitant coronary heart disease
Source: Eur Respir J 2001; 18: Suppl. 33, 25s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept